Posted in FDA PDUFA on Jul 27th, 2010
Remember Isotechnika? ISA.TO (or IPHAF) is the company whose FDA Advisory Panel was cancelled with only a few days notice. The explanation the company gave was vauge at best. However, the company claims the Priority Review PDUFA date of 8/3/10 for Voclosporin is still valid, and they expect to hear from the FDA by that [...]
Posted in Watchlist on Jul 25th, 2010
ARNA – Arena continues its upward momentum, temporarily breaking through $6 on Friday. How long can it continiue this trend? Will it keep advancing as it approaches is FDA Panel? September 16th is a long ways off… I have no position in ARNA, but remember this stock was $2.89 just a month ago. JAZZ – [...]
Posted in Watchlist on Jun 27th, 2010
ISA.TO – Isotechnika has some explaining to do. This company has me concerned. I don’t like the semi-honest first PR from 6/23. If the FDA canceled the meeting due to problems with the application, how can we even expect them to be able to approve this on time? Be careful, this one may slip out [...]
Posted in Breakout on Jun 21st, 2010
Today ISA.TO (IPHAF) hit a 52 week hight at $.43, trading at over 8x its average daily volume. On June 3rd I published an article on ISA.TO (see link here) when the price was at $.27, recommending a buy before the run-up began. Today’s peak represented a 60% gain in price and we still have [...]
Posted in Watchlist on Jun 20th, 2010
ISA.TO (IPHAF) – #1 on the Watchlist this week is Isotechnika Pharma. On Monday of next week (June 28th) they have an FDA Advisory Panel for their main drug, Voclosporin. A reminder to those who are new to trading FDA Panel catalysts, the FDA releases the official “notes” to the meeting a few days ahead [...]
Twitter
Facebook
RSS
Email